ACVR1B and cancer: While all activins commonly trigger Smad4 through ALK4, Act-B and -AB, but not Act-A, could also provoke Smad4-dependent actions via ALK7 [11, 12], which has been reported to potently inhibit cell proliferation and survival in several human cancer cell lines [40-42].